ProShare Advisors LLC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$127,852
-6.4%
14,019
+8.6%
0.00%
Q2 2023$136,535
-9.9%
12,905
+4.1%
0.00%
Q1 2023$151,591
-12.8%
12,395
-11.5%
0.00%
-100.0%
Q4 2022$173,852
+0.5%
14,009
+11.0%
0.00%0.0%
Q3 2022$173,000
-23.5%
12,621
+2.5%
0.00%0.0%
Q2 2022$226,000
-25.2%
12,318
-34.5%
0.00%0.0%
Q1 2022$302,000
-7.1%
18,809
-19.0%
0.00%0.0%
Q4 2021$325,000
-22.2%
23,232
+4.2%
0.00%0.0%
Q3 2021$418,000
-29.4%
22,304
-21.4%
0.00%
-50.0%
Q2 2021$592,000
-19.1%
28,393
+9.7%
0.00%0.0%
Q1 2021$732,000
+0.1%
25,883
+15.7%
0.00%
-33.3%
Q4 2020$731,000
+53.2%
22,380
+43.7%
0.00%
+50.0%
Q3 2020$477,000
+83.5%
15,574
-2.2%
0.00%
+100.0%
Q2 2020$260,000
+30.7%
15,922
+10.2%
0.00%0.0%
Q4 2019$199,000
-18.8%
14,451
-10.5%
0.00%0.0%
Q3 2019$245,000
-11.9%
16,147
+14.2%
0.00%
-50.0%
Q2 2019$278,000
+4.9%
14,142
-11.6%
0.00%0.0%
Q1 2019$265,000
+18.8%
15,996
+0.8%
0.00%0.0%
Q4 2018$223,000
-32.8%
15,873
-16.2%
0.00%0.0%
Q3 2018$332,000
+5.4%
18,949
+9.6%
0.00%0.0%
Q2 2018$315,000
+0.3%
17,288
+3.4%
0.00%0.0%
Q1 2018$314,000
+6.4%
16,720
-13.2%
0.00%0.0%
Q4 2017$295,00019,2700.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$16,871,5179.37%
Prosight Management, LP 1,932,456$17,623,9995.58%
ACUTA CAPITAL PARTNERS, LLC 702,093$6,403,0884.29%
ALETHEA CAPITAL MANAGEMENT, LLC 350,445$3,196,0583.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,335,845$66,902,9063.62%
Affinity Asset Advisors, LLC 856,535$7,811,5992.20%
TCG Crossover Management, LLC 1,423,642$12,983,6151.91%
EcoR1 Capital, LLC 5,806,871$52,958,6641.79%
BVF INC/IL 6,730,983$61,386,5651.66%
DAFNA Capital Management LLC 550,784$5,023,1501.56%
View complete list of KURA ONCOLOGY INC shareholders